Streetbeat News

Stock Prices

BTCUSD

Veteran trader Tone Vays predicts Bitcoin (BTC) could reach $355,000 by April 2027, citing the introduction of spot market ETFs as a key driver. Vays believes breaking the $84,000 to $85,000 threshold will solidify BTC's position above $65,000, marking a significant bullish trend despite recent volatility.

Portfolio Pulse from Benzinga Neuro

March 06, 2024 | 11:55 am

CRWD

FTNT

PANW

S

ZS

Cybersecurity stocks are trading higher following CrowdStrike's report of better-than-expected Q4 financial results and positive guidance for Q1 and FY25.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:55 am

CRWD

CrowdStrike Holdings' shares surged following a report of better-than-expected Q4 earnings and revenues, along with positive guidance for Q1 and FY25. Analysts have responded by raising their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:54 am

CHPT

ChargePoint Holdings' shares dropped following a Q4 revenue miss and disappointing Q1 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:53 am

JWN

Nordstrom's stock is trading lower due to the company providing weaker than expected earnings per share (EPS) guidance for the fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:52 am

BOX

Box Inc. shares surged following its announcement of higher-than-expected Q4 earnings per share (EPS) and a $100M expansion of its stock repurchase program. Additionally, the company provided Q1 revenue guidance that exceeded analysts' expectations.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:52 am

BASE

Couchbase shares surged following the announcement of Q4 sales surpassing estimates and the company providing optimistic revenue guidance for Q1.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:52 am

KFY

Korn Ferry (NYSE:KFY) exceeded Q3 earnings and sales estimates with an EPS of $1.07, beating the $0.99 forecast, and reported sales of $676.87M, surpassing the $658.50M estimate. This represents a 5.94% increase in EPS and a 1.45% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:52 am

DXCM

DexCom's stock price increased following the announcement of FDA clearance for Stelo, a new product by the company. This regulatory approval is a significant milestone for DexCom, potentially opening up new markets and opportunities for growth.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:51 am

EVC

Entravision shares are trading lower following Meta's decision to terminate its ASP program globally by July 1, impacting all ASPs including Entravision. This program constituted a significant part of Entravision's total consolidated revenue.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 11:51 am